Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by EbbFlow88on Sep 23, 2022 8:18am

RE:RE:Revenue comparison 10 years later

My thoughts exactly. They are certainly buying back here but the volume hasn't been very high so it seems buybacks are muted to save for a deal around the corner. Or they see a bigger market panic ...more  
140
Discussion
Comment by wofatson Sep 22, 2022 6:43pm

RE:Revenue comparison 10 years later

There is about 5 times as many shares of Knight so we are close to being halfway there I would think. If revenue is 80+ for this quarter there is a good chance 300 is within grasp for this year ...more  
145
Discussion
Post by GoldenInvestoron Sep 22, 2022 5:33pm

Revenue comparison 10 years later

2011, Paladin Labs :  $141 Million  , approximate 2021, Knight Therapeutics - $243 Million, approximate
198
Discussion
Comment by Chianchinon Sep 14, 2022 7:20pm

RE:RE:Increasing revenues through pandemic!

BTW for anyone new in this forum Gold and Mugsy is the same person with different alias  pedling a lost cause GUD for ten years and nothing to show for other than huse loses as high as 90% one ...more  
191
Discussion
Comment by MrMugsyon Sep 14, 2022 4:00pm

RE:Increasing revenues through pandemic!

Which is why it's really easy to grow overall revenue based on adding a single drug to ROW. Imagine what you could do with a couple drugs - OR - by adding a portfolio. Same thing if you can bring ...more  
184
Discussion
Post by GoldenInvestoron Sep 14, 2022 1:17pm

Increasing revenues through pandemic!

Looking at the Knight investor fact sheet, august 2022, as the team have grown Knight, incorporating GBT, revenues have increased over $10MM TO $75.8MM. YTD rev increase almost up by $28MM ...more  
211
Discussion
Comment by MrMugsyon Sep 14, 2022 10:29am

RE:RE:RE:ENDO

It is a shame - but - I recall when Goodman pointed out what a mess Endo was in.  His comments were also related generally to the "drunken sailor" approach to buying pharma assets using ...more  
189
Discussion
Comment by wofatson Sep 13, 2022 10:33pm

RE:RE:ENDO

Nasdaq also announced today that it will delist the ordinary shares of Endo International plc. Endo International plc’s shares were suspended on August 26, 2022 and have not traded on Nasdaq since ...more  
142
Discussion
Post by cynthieesson Sep 12, 2022 8:09pm

On watch

Technical indicator Stochastic oscillator and RSI go green. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long ...more  
163
Post by GoldenInvestoron Sep 12, 2022 8:01pm

Cancer Moonshot initiative

Cancer moonshot initiative-  Biden speaking today about beating cancer  we can do this together Cancer ‘Moonshot’ initiative Aim to cut cancer deaths by half over next 25 ...more  
124
Comment by Chianchinon Sep 12, 2022 6:08pm

RE:CNBC guest talking up pharma and biotech

Losers...losers....losers. When will your illusion end
68
Discussion
Post by GoldenInvestoron Sep 12, 2022 4:00pm

CNBC guest talking up pharma and biotech

How cancer will be beaten, other diseases and therapies will be huge discoveries by smaller biotech pharma co, partnerships/ buyouts by bigger companies 
126
Discussion
Comment by MrMugsyon Sep 11, 2022 10:04am

RE:RE:RE:Only 200 shares traded @ 10:15

I missed that - was on a train going to the Antibe AGM. Just love the potential at ATE for GUD shareholders - got my fingers crossed for a future of opportunity there.  Wouldn't surprise me ...more  
176
Discussion
Comment by GoldenInvestoron Sep 10, 2022 4:30pm

RE:RE:Only 200 shares traded @ 10:15

Thanks!  I figured it wasn't but was curious why nothing had traded , just 200 shares u til >+45 mins in. it seemed stranger then picked up thereafter 
117
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities